Pay in 4 interest-free payments of $4.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
June 24th 14:00 PM AM
Assess which pharmacological options may suit each case
MANZCVS Veterinary Ophthalmologist
Phase four is often the due diligence process
Zenrelia: A new treatment to elevate care in canine allergic and atopic dermatitis (LVS25) Bundle June 24th 14:00 PM AMPresented at London Vet Show 2025. 20 Nov 2025 11: 30 12: 30 Gallery Suite 22 This session will focus on your treatment targets when treating atopic patients, data from the Zenrelia clinical trials and real world experience with Zenrelia from some of the UKs leading dermatologists. Learn about Zenrelia (ilunocitinib), Elancos new once daily JAK inhibitor for the treatment of canine allergic and atopic dermatitis which brings 45% more itchy dogs back
US$ 70.00
US$ 111.00
US$ 120.00
US$ 88.00
US$ 99.00
US$ 111.00
US$ 120.00
US$ 111.00
US$ 99.00
US$ 99.00
US$ 88.00
US$ 111.00
US$ 120.00
